Prevalence and characterization of treatment-refractory psoriasis and super-responders to biologic treatment: a nationwide study.
Nikolai Dyrberg LoftAlexander EgebergM K RasmussenL E BryldC V NissenT N DamK K AjgeiyL IversenLone SkovPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
A small proportion of patients with psoriasis treated with biologics are either super-responders or treatment refractory. Treatment refractory patients have higher body weight, whereas super-responders have fewer comorbidities and higher socioeconomic status.